Kaempferol from Moringa oleifera L. increases longevity and ameliorates efavirenz-induced functional senescence in Drosophila melanogaster
7 days
Abstract
Efavirenz acts against human immunodeficiency virus (HIV-1), induces functional senescence, and increases mortality in Drosophila melanogaster (Fruit fly). Kaempferol is a plant-derived flavonoid with neuroprotective and antioxidant properties. This study evaluated the protective effect of Kaempferol on efavirenz-induced functional senescence in D. melanogaster. Kaempferol was isolated from Moringa oleifera leaves. Adult flies (24-72 h old) were exposed to graded concentrations (1-1000 mg/10 g diet) to determine the median lethal concentration (LC₅₀). Sublethal doses (5-50 mg/10 g diet) were used to assess longevity, acute toxicity, fecundity, locomotor performance, and biochemical parameters. For protective evaluation, flies were co-treated with efavirenz (5 mg/10 g diet) and kaempferol (10 or 20 mg/10 g diet) for 7 days. Survival, climbing ability, fecundity, antioxidant biomarkers, and acetylcholinesterase activity were subsequently measured. Kaempferol showed an LC₅₀ of 338.60 mg/10 g diet. Additionally, it significantly improved survival, climbing ability, and reproductive capacity compared to control flies (P < 0.05). It also enhanced the antioxidant status in flies, as evidenced by a significant (P < 0.05) increase in total thiol levels, as well as glutathione S-transferase (GST), catalase (CAT), and superoxide dismutase (SOD) activities, alongside a decrease in malondialdehyde (MDA) concentration. Furthermore, Kaempferol mitigated efavirenz-induced mortality, climbing weakness, reproductive decline, and deficits in acetylcholinesterase (AChE) activity (P < 0.05). Overall, this study demonstrated the chemoprotective potential of Kaempferol against efavirenz-induced mortality and functional senescence in D. melanogaster through antioxidative mechanisms. This, to the best of our knowledge, has not been reported before.
The paper
University of Jos
Toxicology Reports, 25 Jun 2026, Open access


